RMAH — Farmaceutica Remedia SA Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesBalancedMicro CapNeutral

Annual income statement for Farmaceutica Remedia SA, fiscal year end - December 31st, RON millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	441	477	536	593	744
Cost of Revenue
Gross Profit	38	30.5	33.7	33.2	41.2
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	399	468	529	585	731
Operating Profit	42.9	8.79	6.75	8.16	13.1
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	42.8	8.63	7.06	8.91	14.1
Provision for Income Taxes
Net Income After Taxes	37.8	7.23	5.81	7.2	6.96
Net Income Before Extraordinary Items
Net Income	37.8	7.23	5.81	7.2	6.96
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	37.8	7.23	5.81	7.2	6.96
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.024	0.071	0.058	0.064	0.073
Dividends per Share